2013. Clinical performance of the novel DiaSorin LIAISON XL murex: HBsAg Quant, HCV-Ab, HIV-Ab/Ag assays. J Clin Virol.Adalbert Krawczyk,Christian Hintze,Jessica Ackermann,Birgit Goitowski,Martin Trippler,Nico Grüner,Maria Neumann-Fraune,Jens Verheyen,Melanie Fiedler.Clinical performance of the ...
The fully automated and closed LIAISON®XL platform was developed for reliable detection of infection markers like hepatitis B virus (HBV) surface antigen (HBsAg), hepatitis C virus (HCV) antibodies (Ab) or human immunodeficiency virus (HIV)-Ag/Ab. To date, less is known about the diagnostic...
Assessment of new LIAISON XL murex automated immunoassays for detection of HBsAg, anti-HCV and HIV markers in human serum/plasma specimensM., De LucaF., CapuanoD., ZaninS., EnriettiV., AnroS., MorenaL., Pallavicini